Literature DB >> 29453928

CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.

Ali Khalili1, Soheil Ebrahimpour2, Iradj Maleki3, Saeid Abediankenari1, Mousa Mohammadnia Afrouzi4.   

Abstract

BACKGROUND: Regulatory T (Treg) cell plays a key role in autoimmune diseases. We evaluated the regulatory function and frequency of Treg cells and secreted IL-10, IL-35 concentration in Crohn's disease (CD).
METHODS: Twenty-three patients with CD and 25 healthy controls (HC) were included in this study. We analysed the alteration of Tregs frequency using flow cytometry for CD4, CD25, CD127 and FoxP3 markers. Surface expression of CD4, CD25 and CD127 markers were used for isolation of relatively pure Treg cells. Suppressive activity of Tregs was determined by measuring their ability to inhibit the proliferation of T responder (Tres) cells. In addition, the amounts of IL-10 and IL-35 cytokines in co-culture supernatants were measured by ELISA assay after stimulation with anti-CD2/CD3/CD28.
RESULTS: CD patients had significantly lower frequency of CD4+ CD25+ CD127low FoxP3+ Treg cells in comparison with controls (2.17 ± 1.04 vs. 2.83 ± 1.07, p = 0.0352). Additionally, Treg cells mediated suppression was not significantly different in CD patients compared to controls. There was a significant difference in IL-10 secretion in response to anti-CD2/CD3/CD28 stimulation compared with HC (p = 0.0074).
CONCLUSION: The frequency of CD4+ CD25+ CD127low FoxP3+ Tregs decreased in active stage of CD but there was no impaired suppressive function of CD4+ CD25+ CD127low FoxP3+ Treg cells. We suggest that an alteration in the balance of Tregs and T effectors may contribute to pathogenesis of CD.

Entities:  

Keywords:  Crohn’s disease; IL-10; IL-35; Regulatory T cells

Mesh:

Substances:

Year:  2018        PMID: 29453928     DOI: 10.2478/rjim-2018-0006

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  5 in total

1.  A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent Mechanisms.

Authors:  Karli Norville; Denise Skrombolas; Shannon L Ferry; Nolan Kearns; John G Frelinger
Journal:  J Interferon Cytokine Res       Date:  2022-07       Impact factor: 3.657

2.  CD19+CD24hiCD38hi regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C.

Authors:  Qiannan Fang; Yanan Deng; Rongzhen Liang; Yongyu Mei; Zhaoxia Hu; Julie Wang; Jianbo Sun; Xiaohong Zhang; Joseph A Bellanti; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

3.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Decreased Frequency of Intestinal CD39+ γδ+ T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease.

Authors:  Jana Libera; Melanie Wittner; Marcus Kantowski; Robin Woost; Johanna M Eberhard; Jocelyn de Heer; Dominik Reher; Samuel Huber; Friedrich Haag; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

5.  Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis.

Authors:  Chenchen Yang; Fanchao Dai; Rexiti Pulati; Yan Jiao; Qian Xu
Journal:  J Trop Med       Date:  2022-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.